The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
A factor analytic study in bipolar depression, and response to lamotrigine
Open accessAbstract
Objective: There have been no previous factor analytic studies of the Hamilton Depression Rating Scale (HDRS) in samples with bipolar I depression, and no investigations of the utility of any derived factors in determining treatment response in this condition. This study aimed to identify and compare factors of a 31-item version of the HDRS (HDRS-31) in large samples of patients with bipolar depression and Major Depressive Disorder (MDD), then examine the responsiveness of such factors to lamotrigine compared with placebo in the bipolar depressed sample. Methods: This multivariate analytical study was performed on 2 large depressed samples (one bipolar and the other MDD) that had been recruited for separate, contemporaneous, double-blind placebo-controlled trials of lamotrigine. The 2 studies had similar designs and assessment tools, the major measures being the Montgomery–Asberg Depression Rating Scale (MADRS) and HDRS-31. To identify the constructs underlying the scale, exploratory factor analyses were conducted using HDRS-31 baseline scores. Treatment responsiveness in the bipolar depressed sample—as indicated by improvement in the total MADRS and HDRS-31, as well as HDRS factors—were examined using both a mixed-effects analysis and individual time-point t-tests. Results: Seven factors of the HDRS-31 were identified: I—“depressive cognitions,” II—“psychomotor retardation,” III—“insomnia,” IV—“hypersomnia,” V—“appetite and weight change,” VI—“anxiety,” and VII—“anergia.” A significant therapeutic effect of lamotrigine in bipolar depression was found for the “depressive cognitions” factor (from week 3) and “psychomotor retardation” (from week 4). Conclusion: This study has identified 7 factors of the HDRS in a large sample of patients with bipolar depression. The results suggest that that the clinical benefits of lamotrigine in acute bipolar depression are primarily upon depressive cognitions and psychomotor slowing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lamotrigine, however, is well tolerated, and there is some evidence that its effectiveness may be more pronounced in patients experiencing depressive cognitions and psychomotor slowing.309”
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
LISREL 7 : user's reference guide
Jöreskog, K. G., & Sörbom, D. (1989) · Medical Entomology and Zoology · Cited by 9,195
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243 · cited 2×
“In a retrospective long-term longitudinal study, Judd et al.(4,5) found that of time spent symptomatic, depressive symptoms accounted for 32% of weeks in bipolar I (BPI) disorder and 50% of weeks in bipolar II (BPII) disorder, with ratios of time spent depressed vs.”
BackgroundCalabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Self-citationBowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658
Self-citationCalabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0906 · Cited by 635
Self-citationJudd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Leon, A. C., Solomon, D. A., Coryell, W., Maser, J. D., & Keller, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1322 · Cited by 577 · cited 1×
“Bipolar depression also appears to be particularly debilitating,(6) even when symptoms are only subsyndromal.(7) Furthermore, bipolar depression is poorly responsive to extant therapies.”
Background
Research works printed but not linked: 3
- 2001, S-Plus 6 for Windows Guide to Statistics, Volume I
- Laurenza, 1999, A double-blind, placebo-controlled study supporting the efficacy of lamotrigine in unipolar depression, Bipolar Disord, 1, 39
- Muthen, 1998, Mplus User's Guide
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationBesag, F., Vasey, M. J., Sharma, A., & Lam, I. C. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211045870 · Cited by 62
Isa, A., Bernstein, I. H., Trivedi, M. H., Mayes, T. L., Kennard, B. D., & Emslie, G. J. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0127 · Cited by 46
Bobo, W. V., Reilly-Harrington, N. A., Ketter, T. A., Brody, B. D., Kinrys, G., Kemp, D. E., Shelton, R. C., McElroy, S. L., Sylvia, L. G., Kocsis, J. H., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000257 · Cited by 27
Self-citationLamotrigine (Lamictal IR) for the treatment of bipolar disorder
Bowden, C. L., & Singh, V. K. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.741590 · Cited by 20
Self-citation
Metadata
- Authors
- Mitchell, P. B., Hadzi-Pavlovic, D., Evoniuk, G., Calabrese, J. R., & Bowden, C. L.
- Affiliations
- Black Dog Institute (AU)
- Case Western Reserve University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Mitchell, Philip B.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-05-23
- Volume
- 18
- Issue
- 4
- Pages
- 214-224
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W2142310626
- Cited by
- 20
- References
- 36
- Citations by year
- 2024: 2 · 2022: 1 · 2021: 3 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 1
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- green
- handle.unsw.edu.au
- Licence
- cc-by-nc-nd
- www.cambridge.org/core/terms (unspecified)
- Locations
- CNS Spectrums (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- bipolar depression, lamotrigine, Hamilton Depression Rating Scale, factor structure, treatment response, depressive cognitions, psychomotor retardation, major depressive disorder, mood stabilizers
- MeSH terms
- Lamotrigine, Adult, Antidepressive Agents, Bipolar Disorder, Depressive Disorder, Double-Blind Method, Drug Administration Schedule, Factor Analysis, Statistical, Humans, Psychiatric Status Rating Scales, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A factor analytic study in bipolar depression, and response to lamotrigine. https://app.cochat.ai/papers/10.1017/s1092852913000291
- The paper
- Mitchell, P. B., Hadzi-Pavlovic, D., Evoniuk, G., Calabrese, J. R., & Bowden, C. L. (2013). A factor analytic study in bipolar depression, and response to lamotrigine. CNS Spectrums. https://doi.org/10.1017/s1092852913000291
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.